MELFLOR
ActiveSummary
The computed 12-month bankruptcy probability of MELFLOR is 5.9% (elevated). For MELFLOR, one filing cycle of the annual accounts is missing. The 2024 annual accounts show equity of €168,184 and a net result of €101,640. Equity is growing by about 113% per year across the filed financial years. Its solvency ranks better than 58% of 9,838 sector peers (NACE 41, financial year 2024). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
2025
25-04
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
30-09
Financial
Highest result from 2022 to 2024net €101,640 ▲107%
Operating result €142,220, net result €101,640, both a record.
30-09
Financial
Equity above €150,000equity €168,184 ▲153%
A profit in every financial year since 2022 builds equity to €168,184.
23-04
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
14-03
NBB filing
Annual accounts filed
financial year 2022 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.